| Authors: |
Liem CH; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany., Wurm-Kuczera R; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany., Böckle D; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany., Neumann MA; German Lymphoma Alliance (GLA), Alliance, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Teichert M; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Klein Helmkamp M; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Shumilov E; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany., Malburg N; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany., Versteegen T; German Lymphoma Alliance (GLA), Alliance, Germany.; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Görke F; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany., Magno G; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Ludwig-Maximilians-University Munich, Munich, Germany., Ghandili S; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kauer J; German Lymphoma Alliance (GLA), Alliance, Germany.; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Christofyllakis K; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany., Melchardt T; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Cancer Center, Paracelsus Medical University Salzburg, Salzburg, Austria., Dreger P; German Lymphoma Alliance (GLA), Alliance, Germany.; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Ayuk F; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Subklewe M; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Ludwig-Maximilians-University Munich, Munich, Germany., Vučinić V; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany.; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Pott C; German Lymphoma Alliance (GLA), Alliance, Germany.; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Reinhardt HC; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium, Partner site Essen/Düsseldorf, University Hospital Essen, Essen, Germany.; Center for Molecular Biotechnology, University Hospital Essen, Essen, Germany., Lenz G; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany., von Tresckow B; German Lymphoma Alliance (GLA), Alliance, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium, Partner site Essen/Düsseldorf, University Hospital Essen, Essen, Germany., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Borchmann P; German Lymphoma Alliance (GLA), Alliance, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Busse A; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Keller U; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Lymphoma Alliance (GLA), Alliance, Germany.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Cluster of Excellence ImmunoPreCept, Charité-Universitätsmedizin Berlin, Berlin, Germany., Chapuy B; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. bjoern.chapuy@charite.de.; German Lymphoma Alliance (GLA), Alliance, Germany. bjoern.chapuy@charite.de.; German Cancer Consortium, Partner Site Berlin, a Partnership between German Cancer Consortium and Charité-Universitätsmedizin Berlin, Berlin, Germany. bjoern.chapuy@charite.de. |
